Merck & Co.’s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients.

BING NEWS:
  • FDA Requires Boxed Warning of Secondary Cancer Risk for Autologous CAR T-Cell Therapies
    The requirement comes after FDA investigated data showing patients developed secondary T-cell malignancies after CD19- and BCMA-directed CAR T-cell therapies.
    04/19/2024 - 4:05 am | View Link
  • Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate
    Merck MRK has initiated phase III study on its oral KRAS G12C inhibitor candidate, MK-1084, for first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC).
    04/4/2024 - 10:33 pm | View Link
  • Merck swings back into Alzheimer's with $1.1bn Cerevance alliance
    and a litany of failures for other amyloid-targeting therapies – plus the abject failure of the one drug to gain regulatory approval – has undermined the amyloid hypothesis of Alzheimer's.
    08/9/2022 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News